Molecular Therapy Methods and Clinical Development

SJR Rank #1,851H-index: 77SJR: 1.749Best quartile: Q1Open AccessAPC: US$3,900Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Cell Press

Country

United States

Type

journal

SJR by Edition

2022202500.511.52

Subject Categories

  • GeneticsQ1
  • Molecular BiologyQ1
  • Molecular MedicineQ1

Areas: Biochemistry, Genetics and Molecular Biology

Most published research topics

Virus-based gene therapy researchCRISPR and Genetic EngineeringCAR-T cell therapy researchRNA Interference and Gene DeliveryViral Infectious Diseases and Gene Expression in InsectsViral Infections and Immunology ResearchRetinal Development and DisordersLysosomal Storage Disorders ResearchImmune Cell Function and InteractionMuscle Physiology and Disorders

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

20222025065130195260

Detailed Information

ISSN

2329-0501

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

4.23

References per Document

51.98

Coverage

2014-2025

Scope

The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella. Topics of particular interest within the journal's scope include: Gene vector engineering and production, Methods for targeted genome editing and engineering, Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells, Methods for gene and cell vector delivery, Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, Analysis of gene and cell vector biodistribution and tracking, Pharmacology/toxicology studies of new and next-generation vectors, Methods for cell isolation, engineering, culture, expansion, and transplantation, Cell processing, storage, and banking for therapeutic application, Preclinical and QC/QA assay development, Translational and clinical scale-up and Good Manufacturing procedures and process development, Clinical protocol development, Computational and bioinformatic methods for analysis, modeling, or visualization of biological data, Negotiating the regulatory approval process and obtaining such approval for clinical trials.

Metrics from SCImago Journal Rank 2025. View on SCImago